Statistical details
Model | Peak caller | Model ID | Enrichment Zone | TFBSs | Score threshold | Centrality p-value (log10) |
---|---|---|---|---|---|---|
DAMO | MACS | MA0024.3 | 63.5 | 6613 | 82.6 | -0.000138745524908184 |
42 datasets found for the same TF (E2F1) in other cell-types/tissues
TF Name | Cell-line | Condition/Source | Collections | Species | Identifiers | JASPAR ID |
---|---|---|---|---|---|---|
E2F1 | dendritic cells | LPS, 0 min | Permissive | Mus musculus | GSE36099 ... | MA0024.3 |
E2F1 | dendritic cells | LPS, 120 min | Permissive | Mus musculus | GSE36099 ... | MA0024.3 |
E2F1 | dendritic cells | LPS, 30 min | Permissive | Mus musculus | GSE36099 ... | MA0024.3 |
E2F1 | dendritic cells | LPS, 60 min | Permissive | Mus musculus | GSE36099 ... | MA0024.3 |
E2F1 | OCI-LY1 (diffuse large B-cell lymphoma) | DMSO | Permissive Robust | Homo sapiens | GSE46663 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | Vehicle | Permissive Robust | Homo sapiens | GSE49832 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | BICALUTAMIDE | Permissive Robust | Homo sapiens | GSE49832 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | Vehicle | Permissive Robust | Homo sapiens | GSE49832 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | BICALUTAMIDE | Permissive Robust | Homo sapiens | GSE49832 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | Vehicle | Permissive Robust | Homo sapiens | GSE49832 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | BICALUTAMIDE | Permissive Robust | Homo sapiens | GSE49832 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | BICALUTAMIDE | Permissive Robust | Homo sapiens | GSE49832 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | Vehicle | Permissive Robust | Homo sapiens | GSE49832 ... | MA0024.3 |
E2F1 | embryonic fibroblasts | E2F1 KO | Permissive | Mus musculus | GSE71376 ... | MA0024.3 |
E2F1 | Raji (Burkitt lymphoma) | 100 nM of JQ1 | Permissive Robust | Homo sapiens | GSE76191 ... | MA0024.3 |
E2F1 | MM1.S (plasma cell myeloma) | none | Permissive Robust | Homo sapiens | GSE80661 ... | MA0024.3 |
E2F1 | U266 (plasma cell myeloma) | none | Permissive | Homo sapiens | GSE80661 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | Treatment: CDT for 72 hrs Genotype: knockdown with shRB of RB | Permissive Robust | Homo sapiens | GSE94958 ... | MA0024.3 |
E2F1 | LNCaP (prostate carcinoma) | Treatment: CDT for 72 hrs Genotype: knockdown with shCON of CON | Permissive Robust | Homo sapiens | GSE94958 ... | MA0024.3 |
E2F1 | U87 (glioblastoma) | Treatment: Mock | Permissive Robust | Homo sapiens | GSE99171 ... | MA0024.3 |
E2F1 | embryonic stem cells | Growth: serum conditions | Permissive Robust | Mus musculus | GSE99847 ... | MA0024.3 |
E2F1 | 2TS22C (embryonic stem cells) | Growth: 2i conditions | Permissive Robust | Mus musculus | GSE99847 ... | MA0024.3 |
E2F1 | HeLa S3 (cervical adenocarcinoma) | Permissive Robust | Homo sapiens | ENCSR000EVJ | MA0024.3 | |
E2F1 | K562 (myelogenous leukemia) | Permissive Robust | Homo sapiens | ENCSR563LLO | MA0024.3 | |
E2F1 | K562 (myelogenous leukemia) | Permissive Robust | Homo sapiens | ENCSR720HUL | MA0024.3 | |
E2F1 | embryonic stem cells | Permissive | Mus musculus | GSE11431 ... | MA0024.3 | |
E2F1 | MCF7 (Invasive ductal breast carcinoma) | Permissive | Homo sapiens | GSE28286 ... | MA0024.3 | |
E2F1 | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | GSE28286 ... | MA0024.3 | |
E2F1 | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | GSE28286 ... | MA0024.3 | |
E2F1 | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | GSE28286 ... | MA0024.3 | |
E2F1 | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | GSE28286 ... | MA0024.3 | |
E2F1 | embryonic fibroblasts | Permissive Robust | Mus musculus | GSE71376 ... | MA0024.3 | |
E2F1 | hepatocytes | Permissive Robust | Mus musculus | GSE74006 ... | MA0024.3 | |
E2F1 | Raji (Burkitt lymphoma) | Permissive Robust | Homo sapiens | GSE76191 ... | MA0024.3 | |
E2F1 | PC3(bone mets prostate adenocarcinoma) | Permissive | Homo sapiens | GSE77448 ... | MA0024.3 | |
E2F1 | MDA231-LM2-4175 (breast adenocarcinoma) | Permissive | Homo sapiens | GSE95303 ... | MA0024.3 | |
E2F1 | hTERT-RPE1 | Permissive Robust | Homo sapiens | GSE69147 ... | MA0024.3 | |
E2F1 | U2OS (osteosarcoma) | Permissive Robust | Homo sapiens | GSE69147 ... | MA0024.3 | |
E2F1 | Permissive Robust | Homo sapiens | GSE62425 | MA0024.3 | ||
E2F1 | LNCaP-abl (Prostate carcinoma) | Permissive Robust | Homo sapiens | GSE67809 | MA0024.3 | |
E2F1 | Permissive | Homo sapiens | GSE68223 | MA0024.3 | ||
E2F1 | Permissive Robust | Homo sapiens | GSE77260 | MA0024.3 |